Showing results (2231-2240 of 2,570) with videos related to
Sort By:
Pageof 257
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 29, 2024
Systemic delivery of proteins using novel peptides via the sublingual routeJiamin Wu, Natalie Jones, Lukas Hohenwarter, et al.Human Gene Therapy|September 9, 2004
Long-term correction of murine lipoprotein lipase deficiency with AAV1-mediated gene transfer of the naturally occurring LPL(S447X) beneficial mutationColin J D Ross, Jaap Twisk, Janneke M Meulenberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2006
Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-DBradford A Moffat, Mark Chen, Muhammed S T Kariaapper, et al.Anti-Cancer Drugs|November 29, 2007
A phase I safety, tolerability, and pharmacokinetic study of enzastaurin combined with capecitabine in patients with advanced solid tumorsD Ross Camidge, S Gail Eckhardt, Lia Gore, et al.Journal of the American Society of Nephrology : JASN|February 24, 2006
Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal diseaseMichael J Ross, Matthew S Wosnitzer, Michael D Ross, et al.Toxicological Sciences : an Official Journal of the Society of Toxicology|August 10, 2016
Identification of Drug-Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-Derived CardiomyocytesDaniel C Millard, Christopher J Strock, Coby B Carlson, et al.Cancer Discovery|July 31, 2014
Dual inhibition of EGFR with afatinib and cetuximab in kinase inhibitor-resistant EGFR-mutant lung cancer with and without T790M mutationsYelena Y Janjigian, Egbert F Smit, Harry J M Groen, et al.Cancer Research Communications|July 21, 2026
Targeting Wild-type NTRK in NTRK Fusion-Negative Lung Cancer Decreases Brain MetastasesMaria J Contreras-Zárate, Jenny A Jaramillo-Gómez, R Alejandro Marquez-Ortiz, et al.Molecular Cancer Therapeutics|January 12, 2011
Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924Xiaonan Hou, Fei Huang, Joan M Carboni, et al.Nature Communications|August 23, 2025
Evolutionary age correlates with range size across plants and animalsAdriana Alzate, Roberto Rozzi, Julian A Velasco, et al.Pageof 257